Ainovo Biotech Inc. applications

Antibiotic resistance is the most insidious public health challenge of our time. AINovo discovers novel therapeutics to alleviate the burden of antibiotic-resistance and battle emerging pathogenic threats.

AlNovo is pioneering new therapeutic modalities based on our Novobinder Platform to harness the power of the human immune system to directly attack cancer cells

AlNovo is applying our Novobinder technology to better understand the processes of pathogenesis and to drive improved outcomes in precision medicine.